Macrophage Inflammatory Protein-1α (MIP-1α) Is Required for the Efferent Phase of Pulmonary Cell-Mediated Immunity to a Cryptococcus neoformans Infection

Journal of Immunology

Volumn 159, Issue 1, 1997, Pages 318-327

  Huffnagle, Gary B ^a   Strieter, Robert M ^b   McNeil, Lisa K ^b   McDonald, Roderick A ^b   Burdick, Marie D ^b   Kunkel, Steven L ^b   Toews, Galen B ^b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MACROPHAGE INFLAMMATORY PROTEIN 1; MESSENGER RNA; MONOCLONAL ANTIBODY;

ANIMAL; ARTICLE; CBA MOUSE; CELLULAR IMMUNITY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FEMALE; IMMUNOLOGY; LUNG; LUNG ALVEOLUS MACROPHAGE; MICROBIOLOGY; MOUSE; PATHOLOGY;

ANIMALS; ANTIBODIES, MONOCLONAL; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FEMALE; IMMUNITY, CELLULAR; LUNG; MACROPHAGE INFLAMMATORY PROTEIN-1; MACROPHAGES, ALVEOLAR; MICE; MICE, INBRED CBA; RNA, MESSENGER;

EID: 0031184059     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Huffnagle, G. B., and G. B. Toews. 1996. Mechanisms of macrophage recruitment into infected lungs. In Lung Macrophages and Dendritic Cells, Vol. 102. M. F. Lipscomb and S. Russell, eds. Marcel Dekker, New York, p. 373.
2. Huffnagle, G. B., and M. F., Lipscomb. 1992. Animal model of human disease: pulmonary cryptococcosis. Am. J. Pathol. 141:1517.
3. Diamond, R. D. 1995. Cryptococcus neoformans. In Principles and Practice of Infectious Diseases. G. L. Mandell, J. E. Bennett, and R. Dolin, eds. Churchill Livingstone, New York, p. 2331.
4. Murphy, J. W. 1989. Cryptococcosis. In Immunology of the Fungal Diseases. R. A. Cox, ed. CRC Press, Boca Raton, p. 93.
5. + T cells in vivo decreases pulmonary clearance of a moderately virulent strain of Cryptococcus neoformans. J. Lab. Clin. Med. 121:765.
6. +) lymphocytes in vivo impairs murine host defense to Cryptococcus neoformans. J. Immunol. 144:1472.
7. + T cells in the protective inflammatory response to a pulmonary cryptococcal infection. J. Leukocyte Biol. 55:35.
8. + T cells. J. Exp. Med. 173:793
9. + T cells. J. Exp. Med. 173:755.
10. + T cells cause multinucleated giant cells to form around Cryptococcus neoformans and confine the yeast within the primary site of infection in the respiratory tract. J. Exp. Med. 175:1685.
11. Lovchik, J. A., C. R. Lyons, and M. F. Lipscomb. 1995. A role for gamma inerferon-induced nitric oxide in pulmonary clearance of Cryptococcus neoformans. Am. J. Respir. Cell Mol. Biol. 13:116.
12. Hoag, K. A., N. E. Street, G. B. Huffnagle, and M. F. Lipscomb. 1995. Early cytokine production in pulmonary Cryptococcus neoformans infections distinguishes susceptible and resistant mice. Am. J. Respir. Cell Mol. Biol. 13:487.
13. Huffnagle, G. B., J. L. Yates, and M. F. Lipscomb. 1991. T cell-mediated immunity in the lung: a Cryptococcus neoformans pulmonary infection model using SCID and athymic nude mice. Infect. Immun. 59:1423.
14. Curtis, J. L., G. B. Huffnagle, G. H. Chen, M. L. Warnock, M. R. Gyetko, R. A. McDonald, P. J. Scott, and G. B. Toews. 1994. Experimental murine pulmonary cryptococcosis: differences in pulmonary inflammation and lymphocyte recruitment induced by two encapsulated strains of Cryptococcus neoformans. Lab. Invest. 71:113.
15. Huffnagle, G. B., G. H. Chen, J. L. Curtis, R. A. McDonald, R. M. Strieter, and G. B. Toews. 1995. Down-regulation of the afferent phase of T cell-mediated immunity and pulmonary inflammation by high melanin-producing strain of C. neoformans. J. Immunol. 155:3507.
16. Lovchik, J., M. Lipscomb, and C. R. Lyons. 1997. Expression of lung inducible nitric oxide synthase protein does not correlate with nitric oxide production in vivo in a pulmonary immune response against Cryptococcus neoformans. J. Immunol. 158:1772.
17. Bulmer, G., and J. Tacker. 1975. Phagocytosis of Cryptococcus neoformans by alveolar macrophages. Infect. Immun. 11:73.
18. Chen, G. H., J. L. Curtis, C. H. Mody, P. J. Christensen, L. R. Armstrong, and G. B. Toews. 1994. Effect of granulocyte-macrophage stimulating factor on rat alveolar macrophage anticryptococcal activity in vitro. J. Immunol. 152:724.
19. Collins, H. L., and G. J. Bancroft. 1992. Cytokine enhancement of complement-dependent phagocytosis by macrophages; synergy of tumor necrosis factor-α and granutocyte-macrophage colony-stimulating factor for phagocytosis of Cryptococcus neoformans. Eur. J. Immunol. 22:1447.
20. Kozel, T. R., and T. R. McGraw. 1979. Opsonization of Cryptococcus neofurmans by human immunoglobuiin G: role of immunoglobulin G in phagocytosis by macrophages. Infect. Immun. 25:255.
21. Kozel, T., B. Highison, and C. Stratton. 1984. Localization on encapsulated Cryptococcus neoformans of serum components opsonic for phagocytosis by macro-phages and neutrophils. Infect. Immun. 43:574.
22. Levitz, S. M., and D. J. DiBenedetto. 1989. Paradoxical role of capsule in murine bronchoalveolar macrophage-mediated killing of Cryptococcus neoformans. J. Immunol. 142:659.
23. Levitz, S. M., and A. Tabuni, 1991. Binding of Cryptococcus neoformuns by human cultured macrophages: requirements for multiple complement receptors and actin. J. Clin. Invest. 87.-528.
24. Mody, C. H., C. L. Tyler, R. G. Sitrin, C. Jackson, and G. B. Toews. 1991. Inerferon-gamma activates rat alveolar macrophages for anticryptococcal activity. Am. J. Respir. Cell Mol. Biol. 5:19.
25. Vecchiarelli, A., M. Dottorini, D. Pietrella, C. Monari, C. Retini, T. Todisco, and F. Bistoni. 1994. Role of human alveolar macrophages as antigen-presenting cells in Cryptococcus neoformans infection. Am. J. Respir. Cell Mol. Biol. 11:130.
26. Stricter, R. M., T. J. Standiford, G. B. Huffnagle, L. M. Colletti, N. W. Lukacs, and S. L. Kunkel. 1996. "The good, the bad, and the ugly": the role of chemokines in models of human disease. J. Immunol. 156:3583.
27. Schall, T. J. 1991. Biology of the RANTES/SIS cytokine family. Cytokine 3:165.
28. Oppenheim, J. J., and C. O. C. Zachariae. 1991. Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu. Rev. Immunol. 9:617.
29. Kunkel, S. L., R. M. Stricter, I. J. Lindley, and J. Westwick. 1995. Chemokines: new ligands, receptors and activities. Immunol. Today 16:559.
30. + T cells during a pulmonary Cryptococcus neoformans infection, J. Immunol. 155:4790.
31. Lukacs, N. W., S. L. Kunkel, R. M. Stricter, K. Warmington, and S. W. Chensue. 1993. The role of macrophage inflammatory protein-1 alpha in Schistosoma mansoni egg-induced granulomatous inflammation. J. Exp. Med. 177:1551.
32. Cook, D. N., M. A. Beck, T. M. Coffman, S. L. Kirby, J. F. Sheridan, I. B. Pragnell, and O. Smithies. 1995. Requirement of MIP-1α for an inflammatory response to viral infection. Science 269:1583.
33. Doyle, H. A., and J. W. Murphy. 1997. MIP-1α contributes to the anticryptococcal delayed-type hypersensitivity reaction and protection against Cryptococcus neoformans. J. Leukocyte Biol. 61:147.
34. Martin, C. A., and M. E. Dorf. 1991. Differential regulation of interleukin-6, macrophage inflammatory protein-1, and JE/MCP-1 cytokine expression in macrophage celt lines. Cell. Immunol. 135:245.
35. Paxton, W. A., S. R. Martin, D. Tse, T. R. OBrien, J. Skurnick, N. L. VanDevanter, N. Padian, J. F. Braun, D. P. Kotler, S. M. Wolinsky, and R. A. Koup. 1996. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure. Nat. Med. 2:412.
36. + T cells. Science 270:1811.
37. Feldmesser, M., and A. Casadevall, 1997. Effect of serum IgG1 to Cryptococcus neoformans glucuronoxylomannun on murine pulmonary infection, J. Immunol. 158:790.
38. Smith, R. E., R. M. Stricter, S. H. Phan, N. W. Lukacs. O. B. Huffnagle, C. A. Wilke, M. D. Burdick, P. Lincoln, H. Evanoff, and S. L. Kunkel. 1994. Production and function of murine macrophage inflammatory protein-lα in bleomycin-induced lung injury. J. Immunol. 153:4704.
39. Huffnagle, G. B., G. B. Toews, M. D. Burdick, M. B. Boyd, K. S. McAllister, R. A. McDonald, S. L. Kunkel, and R. M. Stricter. 1996. Afferent phase production of TNF-α is required for the development of protective T cell immunity to C. neoformans. J. Immunol. 157:4529.
40. Evanoff, H. L. M. D. Burdick, S. A. Moore, S. L. Kunkel, and R. M. Stricter. 1992. A sensitive ELIS A for the detection of human monocyte chemoattractant protein-1 (MCP-1). Immunol. Invent. 21:39.
41. Davatelis. G., O. P. Tekamp, S. D. Wolpe, K. Hermsen, C. Luedke, C. Gallegos, D. Coit, J. Merryweather, and A. Cerami. 1988. Cloning and characterization of a cDNA for murine macrophage inflammatory protein (MIP), a novel monokine with inflammatory and chemokinetic properties. J. Exp. Med. 167:1939.
42. VanOtteren, G. M., T. J. Standiford, S. L. Kunkel, J. M. Danforth, M. D. Burdick, L. V. Abruzzo, and R. M. Stricter. 1994. Expression and regulation of macrophage inflammatory prolein-1 alpha by murine alveolar and peritoneal macrophages. Am. J. Respir. Cell Mol. Biol. 10:8.
43. + T cells in response to MIP-1 α and MIP-1β. Science 260:355.
44. Standiford, T. J., S. L. Kunkel, N. W. Lukacs, M. J. Greenberger, J. M. Danforth, R. G. Kunkel, and R. M. Strieter. 1995. Macrophage intflammatory protein-1 α mediates lung leukocyte recruitment, lung capillary leak, and early mortality in murine endotoxemia. J. Immunol. 155:1515.
45. Shanley, T. P., H. Schmal, H. P. Friedl, M. L. Jones, and P. A. Ward. 1995. Role of macrophage inflammatory protein-1α (MIP-lα) in acute lung injury in rats. J. Immunol. 154:4793.
46. Standiford, T. J., S. L. Kunkel, M. J. Greenherger, L. L. Laichalk, and R. M. Stricter. 1996. Expression and regulation of chemokines in bacterial pneumonia. J. Leukocyte Biol. 59:24.
47. McColl, S. R., M. Hachicha, S. Levasseur, K. Neote, and T. J. Schall. 1993. Uncoupling of early signal transduction events from effector function in human peripheral blood neutrophils in response to recombinant macrophage inflammatory proteins-lα and -1β. J. Immunol. 150:4550.
48. Alam, R., D. Kumar, W. D. Anderson, and P. A. Forsythe. 1994. Macrophage inflammatory protein-1 α and monocyte chemoattractant peptide-1 elicit immediate and late cutaneous reactions and activate murine mast cells in vivo. J. Immunol. 152:1298.
49. Appelberg, R. 1992. Macrophage inflammatory proteins MIP-1 and MIP-2 are involved in T cell-mediated neutrophil recruitment. J. Leukocyte Biol. 52:303.,
50. Taub, D. D., A. R. Lloyd, J. M. Wang, J. J. Oppenheim, and D. J. Kelvin, 1993. The effects of human recombinant MIP-1 alpha, MIP-1 beta, and RANTES on the chemotaxis and adhesion of T cell subsets, Adv. Exp. Med. Biol 351:139.
51. Schall, T. J., K. Bacon, R. D. Camp, J. W. Kaspari, and D. V. Goeddel. 1993. Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes. J. Exp. Med. 177:1821.
52. Fahey, T. J., K. J. Tracey, O. P. Tekamp, L. S. Cousens, W. G. Jones, G. T. Shires, A. Cerami, and B. Sherry. 1992, Macrophage inflammatory protein-1 modulates macrophage function. J. Immunol. 148:2764.
53. Lovchik, J., and M. Lipscomb. 1993. Role for C5 and neutrophils in the pulmonary intravascular clearance of circulating Cryptococcus neoformans. Am. J. Respir. Cell Mol. Biol 9:617.